$BCRX Company News Hazmat-suit maker’s shares jump on

New Post Public Reply Private Reply Replies (0) Message Board

Nov 2, 2014 at 11:48 AM

$BCRX Company News

Hazmat-suit maker’s shares jump on Ebola orders 11:49 a.m. Oct. 30, 2014 - Russ Britt
Ebola stocks mostly higher after virus confirmed in New York 1:59 p.m. Oct. 24, 2014 - Joseph Adinolfi
Fighting Ebola though investing: one firm’s approach 5:43 p.m. Oct. 21, 2014 - Wallace Witkowski
Is there an Ebola bubble in these stocks? 2:22 p.m. Oct. 16, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 11:09 a.m. Oct. 13, 2014 - The Trading Deck
U.S. to start screening for Ebola at five airports 5:25 p.m. Oct. 8, 2014 - Russ Britt
Ebola vaccine use likely to be confined, experts say 6:28 a.m. Oct. 8, 2014 - Russ Britt
Number of companies fighting Ebola grows, one wins fed OK 3:09 p.m. Oct. 6, 2014 - Russ Britt
Meet the drug companies fighting Ebola 3:14 p.m. Oct. 3, 2014 - Russ Britt
Getting Ebola treatments to market may take time 2:05 p.m. Oct. 1, 2014 - Russ Britt
Profiting from the fear as the market’s best quarter of the year begins 7:59 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira surges after Ebola report; ADP sinks 7:13 a.m. Oct. 1, 2014 - Ben Eisen
Stock markets start new quarter in good shape. 3:45 a.m. Oct. 1, 2014 - MarketWatch
Newscast: Wall Street notches winning quarter 5:31 p.m. Sept. 30, 2014 - MarketWatch
Use caution when investing in Ebola-related stocks 11:26 a.m. Aug. 28, 2014 - The Trading Deck
In focus: Bulls overconfident? 7:36 p.m. Aug. 13, 2014 - Lawrence G. McMillan
Ebola drug maker's shares soar as FDA opens door to treatment use 11:20 a.m. Aug. 8, 2014 - Russ Britt
6 stocks to watch 2:13 p.m. June 4, 2014 - The Trading Deck
S&P 500 reaches uncharted territory (that’s bullish) 12:00 p.m. March 5, 2014 - Michael Ashbaugh
U.S. stocks rise on ‘buy-the-dip’ mentality 3:31 p.m. April 8, 2013 - Kate Gibson

CDC issues new guidelines over Ebola 4:10 a.m. Oct. 28, 2014 - Seeking Alpha
Ebola Hits NYC: Time To Panic 8:45 a.m. Oct. 27, 2014 - Seeking Alpha
BioCryst Pharmaceutical: Short-Term Pump-And-Dump On Ebola Fear, A Long-Term Hold On Pipeline 10:24 a.m. Oct. 25, 2014 - Seeking Alpha
Making Money With Charles Payne: 10/24/14 6:00 p.m. Oct. 24, 2014 - FOXBusiness
Mali confirms first Ebola case 4:48 a.m. Oct. 24, 2014 - Seeking Alpha
NYC doctor tests positive for Ebola; futures slip 9:57 p.m. Oct. 23, 2014 - Seeking Alpha
New Ebola Fears in NYC Make Major Ebola Stock Waves 2:40 p.m. Oct. 23, 2014 - 247WallSt.com
5 Ebola Stocks Making Massive Moves 8:03 a.m. Oct. 22, 2014 - InvestorPlace.com
5 Ebola Stocks Making Massive Moves 8:03 a.m. Oct. 22, 2014 - InvestorPlace.com
Ebola Stock Fallout Severe on Monday 9:59 a.m. Oct. 20, 2014 - 247WallSt.com
Stomach-Churning Ride for Ebola Stocks 2:52 p.m. Oct. 17, 2014 - FOXBusiness
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog 2:34 p.m. Oct. 17, 2014 - Zacks.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Sarepta Therapeutics Shares Up On Ebola Drug Safety Study 9:58 a.m. Oct. 17, 2014 - benzinga.com
Making Money With Charles Payne: 10/16/14 6:00 p.m. Oct. 16, 2014 - FOXBusiness
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 14.7% - Tale of the Tape 9:25 a.m. Oct. 16, 2014 - Zacks.com
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX) 10:01 a.m. Oct. 15, 2014 - TheStreet.com
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha

BioCryst to Announce Third Quarter 2014 Financial Results November 6 5:56 a.m. Oct. 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014 5:59 a.m. Oct. 8, 2014 - GlobeNewswire
BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress 6:07 a.m. Oct. 7, 2014 - GlobeNewswire
Critical Alerts For Alibaba, BioCryst Pharmaceuticals, Trina Solar Limited, Vipshop Holdings and Visa Released By InvestorsObserver 8:31 a.m. Oct. 2, 2014 - PR Newswire - PRF
BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases 11:07 a.m. Sept. 18, 2014 - GlobeNewswire
BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting 10:00 a.m. Sept. 6, 2014 - GlobeNewswire
BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies 1:31 a.m. Sept. 4, 2014 - GlobeNewswire
BioCryst to Present at Rodman & Renshaw Conference 5:35 a.m. Sept. 3, 2014 - GlobeNewswire
BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting 5:52 a.m. Sept. 2, 2014 - GlobeNewswire
BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease 6:07 a.m. Aug. 29, 2014 - GlobeNewswire
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases 6:04 a.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 2:04 p.m. Aug. 12, 2014 - ACCESSWIRE
BioCryst Reports Second Quarter 2014 Financial Results 5:56 a.m. Aug. 5, 2014 - GlobeNewswire
BioCryst to Announce Second Quarter 2014 Financial Results August 5 6:06 a.m. July 22, 2014 - GlobeNewswire
Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum Pharma, Exact Sciences, and Vical Inc. 8:10 a.m. July 21, 2014 - PR Newswire - PRF
Theravance, Inc. Appoints George B. Abercrombie as Senior Vice President, Corporate Partnerships, Commercial 4:15 p.m. June 12, 2014 - Marketwire
BioCryst Announces Exercise of Over-Allotment Option and Completion of Public Offering 9:40 a.m. June 3, 2014 - GlobeNewswire
BioCryst to Present at Two Upcoming Investor Conferences 12:05 p.m. June 2, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

American Tire Distributors Shifts Gears in Leadership

Another Day, Another Leadership Shuffle at ATD Well, the wheel's turning again at American Tire Distributors (ATD). The crew in Huntersville, N.C., just put Michael Broderick in the driver's seat as Interim President, replacing Ira B. Silver. And they've parted ways with him—done and dusted. This isn't just some random pick; Broderick's been kickin' around ATD's Board...

INSIS Redefines Comfort with Subtle Chinese Design

The Harmony of Fabric and Form Diving into how INSIS defines 'Natural Ease' is like watching an artist paint with subtlety. They’re moving beyond the mere appeal of their fabrics to craft a quieter conversation between the fabric, the body, and everyday life. They focus heavily on the material—17.5-micron superfine Aussie merino wool takes center stage, backed up by...

Dr. Schult Wins 2026 People Helping People Award

Dr. Deborah Schult: A Pioneer in Correctional Healthcare If you've been in the business of behavioral healthcare, particularly in correctional environments, then you know the name Dr. Deborah Schult is one that resonates with seasoned respect. This year's People Helping People Award from the American Board of Correctional Psychology shines a well-deserved spotlight on her...

JELD-WEN Schedules Q3 2026 Earnings Call Amid Global Reach

Looking Ahead: JELD-WEN's Q3 Results Exploration Alright folks, buckle up. JELD-WEN Holding, Inc., the name any DIY'er worth their salt recognizes for doors and windows, has set the stage for unveiling its third quarter 2026 performance. They've earmarked November 3 post-market for us to comb through the numbers, and they're wasting no time by getting on a conference call...

Lawsuit Filed for Unfair ODP Acquisition Price

Is ODP Getting a Raw Deal? Grab a cup of joe, because this is one of those sticky situations where the stakes are high, and the details are grimmer than last week's sales report. On August 19, 2026, Monteverde & Associates PC filed a lawsuit targeting the acquisition of The ODP Corporation by Atlas Holdings LLC, claiming the buyout price wasn't just low—it was roaringly...

New CEO at Simpli.fi: Sean McCaffrey Takes Charge

A New Captain at Simpli.fi's Helm In the fast-paced world of digital advertising, Simpli.fi isn't just sitting on the sidelines. They've gone and snagged Sean McCaffrey as their new CEO. Now, for those who remember GSTV's rise to 30,000 locations under McCaffrey, this appointment carries some serious weight. McCaffrey's Track Record: Setting the Pace McCaffrey's no...

DaVita's Stand on HHS Kidney Plan: Innovation at Core

DaVita Stands Firm on Kidney Care Innovation The healthcare landscape's shifting undercurrent, folks, and kidney care has landed smack in the spotlight with the U.S. Department of Health and Human Services (HHS) putting forth its Kidney Care National Plan. Now, this isn't some bureaucratic mumbo-jumbo—this plan's setting the tone for kidney disease treatment across...

Arbor Scientia Snags Second Consecutive BASA Win

Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...

Anita Eno: 2027's Top Trailblazing Businesswoman

Anita Eno's Well-Deserved Recognition You've got to respect a story where someone claws their way up from humble beginnings to a position of serious influence. Anita Eno, Founder and CEO of Prayers Are Answered Inc., is one of those impressive figures, recently bagging the 2027 American Business Woman of the Year title. This accolade, dished out by the American Business...

Dairy Blends Market Eyes USD 15.38B by 2035 Growth

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...